DeepMed Research

UNIVERSITY OF ALABAMA AT BIRMINGHAM

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1969-01-01

Employees: 2K

Market Cap: -

Website: http://www.uab.edu

Clinical Trials

A Multisite Trial of ACQUIREc Therapy

Not Applicable

Completed

Conditions: Hemiparetic Cerebral Palsy

Interventions: Other: Therapy services (ACQUIREc Therapy)

First Posted Date: 2009-10-08

Last Posted Date: 2009-10-08

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 18

Registration Number: NCT00991692

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Study Evaluating the Safety and Tolerability of L-377202

Phase 1

Completed

Conditions: Hormone Refractory Prostate Cancer
Prostate Cancer

Interventions: Drug: L-377202

First Posted Date: 2009-10-01

Last Posted Date: 2023-05-25

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 13

Registration Number: NCT00987753

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Chewing Gum for Weight Loss

Not Applicable

Completed

Conditions: Overweight
Obesity
Weight Loss

Interventions: Behavioral: nutrition brochure
Other: Extra sugar-free chewing gum sticks

First Posted Date: 2009-09-03

Last Posted Date: 2010-11-23

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 200

Registration Number: NCT00971347

Locations: 🇺🇸
University of Alabama at Birmingham Division of Preventive Medicine, Birmingham, Alabama, United States

Endoscopic Ultrasound (EUS) Guided-Celiac Plexus Neurolysis (CPN) in Unresectable Pancreatic Cancer

Not Applicable

Completed

Conditions: Pain
Pancreatic Cancer

Interventions: Procedure: Ultrasound guided celiac plexus neurolysis (CPN)

First Posted Date: 2009-08-28

Last Posted Date: 2014-06-04

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 60

Registration Number: NCT00968175

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Florida Hospital, Orlando, Florida, United States

A Study of an Infectivity Enhanced Suicide Gene Expressing Adenovirus for Ovarian Cancer in Patients With Recurrent Ovarian and Other Selected Gynecologic Cancers

Phase 1

Completed

Conditions: Ovarian Cancer

Interventions: Genetic: Ad5.SSTR/TK.RGD
Drug: Ganciclovir (GCV)

First Posted Date: 2009-08-25

Last Posted Date: 2013-02-13

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 11

Registration Number: NCT00964756

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Standardization of CD3+ T Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation from Matched Related Donors

Not Applicable

Active, not recruiting

Conditions: Hematopoietic Stem Cell Transplantation

Interventions: Device: CD3+ T cell depletion

First Posted Date: 2009-08-14

Last Posted Date: 2024-12-20

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 20

Registration Number: NCT00959140

Locations: 🇺🇸
University of Alabama Hospital, Birmingham, Alabama, United States

Calorie Restriction and Changes in Body Composition, Disease, Function, and Quality of Life in Older Adults

Phase 3

Completed

Conditions: Obesity
Hyperlipidemia
Diabetes
Hypertension

Interventions: Behavioral: Exercise
Behavioral: Weight Maintenance Diet
Behavioral: Reduced Calorie Diet

First Posted Date: 2009-08-10

Last Posted Date: 2017-09-05

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 167

Registration Number: NCT00955903

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Treatment Response in Schizophrenia: Bridging Imaging and Postmortem Studies

Completed

Conditions: Schizophrenia

First Posted Date: 2009-07-13

Last Posted Date: 2021-07-26

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 75

Registration Number: NCT00937716

Locations: 🇺🇸
University of Alabama at Birmingham, Department of Psychiatry, SC 501, Birmingham, Alabama, United States

Tarceva and AT-101 for Patients With Advanced Non-Small Cell Lung Cancer

Phase 1

Withdrawn

Conditions: Carcinoma, Non Small Cell Lung

Interventions: Drug: Tarceva plus AT-101

First Posted Date: 2009-07-08

Last Posted Date: 2015-05-08

Lead Sponsor: University of Alabama at Birmingham

Registration Number: NCT00934076

HIV Viral Load Monitoring in Resource-Poor Settings

Not Applicable

Completed

Conditions: AIDS
HIV
HIV Infections

Interventions: Other: HIV-1 viral load testing

First Posted Date: 2009-06-29

Last Posted Date: 2014-10-09

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 2112

Registration Number: NCT00929604

Locations: 🇿🇲
Centre for Infectious Disease Research in Zambia, Lusaka, Zambia

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy